ZA985203B - Compounds useful for inhibition of farnesyl protein transferase - Google Patents
Compounds useful for inhibition of farnesyl protein transferaseInfo
- Publication number
- ZA985203B ZA985203B ZA985203A ZA985203A ZA985203B ZA 985203 B ZA985203 B ZA 985203B ZA 985203 A ZA985203 A ZA 985203A ZA 985203 A ZA985203 A ZA 985203A ZA 985203 B ZA985203 B ZA 985203B
- Authority
- ZA
- South Africa
- Prior art keywords
- inhibition
- compounds useful
- protein transferase
- farnesyl protein
- farnesyl
- Prior art date
Links
- 102000004357 Transferases Human genes 0.000 title 1
- 108090000992 Transferases Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 125000004030 farnesyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87774197A | 1997-06-17 | 1997-06-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA985203B true ZA985203B (en) | 1999-01-05 |
Family
ID=25370618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA985203A ZA985203B (en) | 1997-06-17 | 1998-06-15 | Compounds useful for inhibition of farnesyl protein transferase |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0989983B1 (es) |
| JP (1) | JP2002504144A (es) |
| KR (1) | KR100640672B1 (es) |
| CN (1) | CN1266433A (es) |
| AR (1) | AR012991A1 (es) |
| AT (1) | ATE273299T1 (es) |
| AU (1) | AU753658B2 (es) |
| CA (1) | CA2293714C (es) |
| DE (1) | DE69825589T2 (es) |
| ES (1) | ES2224408T3 (es) |
| HU (1) | HUP0003138A3 (es) |
| IL (2) | IL133386A0 (es) |
| MY (1) | MY143570A (es) |
| NZ (1) | NZ501376A (es) |
| PE (1) | PE104798A1 (es) |
| TW (1) | TW587935B (es) |
| WO (1) | WO1998057960A1 (es) |
| ZA (1) | ZA985203B (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ511878A (en) * | 1998-12-18 | 2003-10-31 | Schering Corp | Tricyclic farnesyl protein transferase inhibitors |
| KR20010081115A (ko) * | 1998-12-18 | 2001-08-27 | 둘락 노먼 씨. | 파르네실 단백질 트랜스퍼라제 억제제 |
| US6372747B1 (en) | 1998-12-18 | 2002-04-16 | Schering Corporation | Farnesyl protein transferase inhibitors |
| US6800636B2 (en) | 1998-12-18 | 2004-10-05 | Schering Corporation | Farnesyl protein transferase inhibitors |
| US6362188B1 (en) | 1998-12-18 | 2002-03-26 | Schering Corporation | Farnesyl protein transferase inhibitors |
| US6432959B1 (en) * | 1998-12-23 | 2002-08-13 | Schering Corporation | Inhibitors of farnesyl-protein transferase |
| US7342016B2 (en) | 2000-08-30 | 2008-03-11 | Schering Corporation | Farnesyl protein transferase inhibitors as antitumor agents |
| WO2002056884A2 (en) * | 2001-01-22 | 2002-07-25 | Schering Corporation | Treatment of malaria with farnesyl protein transferase inhibitors |
| AU2002257114A1 (en) * | 2001-04-06 | 2002-10-21 | Schering Corporation | Treatment of malaria with farsenyl protein transferase inhibitors |
| US7754722B2 (en) | 2002-09-20 | 2010-07-13 | Merck Serono Sa | Piperazine derivatives and methods of use |
| CN101115486A (zh) | 2004-12-13 | 2008-01-30 | 先灵公司 | 新的法呢基蛋白转移酶抑制剂及其治疗癌症的用途 |
| WO2006065794A1 (en) | 2004-12-14 | 2006-06-22 | Schering Corporation | Farnesyl protein transferase inhibitors and methods for treating proliferative diseases |
| WO2013110134A1 (en) * | 2012-01-25 | 2013-08-01 | Spinifex Pharmaceuticals Pty Ltd | Heterocyclic compounds and methods for their use |
| US10875851B2 (en) | 2016-11-18 | 2020-12-29 | Merck Sharp & Dohme Corp. | Factor XIIa inhibitors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE210652T1 (de) * | 1993-10-15 | 2001-12-15 | Schering Corp | Tricyclische carbamat-derivate zur inhibierung der g-protein funktion und für die behandlung von proliferativen erkrankungen |
| IL111235A (en) * | 1993-10-15 | 2001-03-19 | Schering Plough Corp | Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them |
| IL117798A (en) * | 1995-04-07 | 2001-11-25 | Schering Plough Corp | Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them |
| IL117797A0 (en) * | 1995-04-07 | 1996-08-04 | Pharmacopeia Inc | Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| US5712280A (en) * | 1995-04-07 | 1998-01-27 | Schering Corporation | Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
-
1998
- 1998-06-15 TW TW087109501A patent/TW587935B/zh not_active IP Right Cessation
- 1998-06-15 KR KR1019997011842A patent/KR100640672B1/ko not_active IP Right Cessation
- 1998-06-15 IL IL13338698A patent/IL133386A0/xx active IP Right Grant
- 1998-06-15 AU AU80580/98A patent/AU753658B2/en not_active Ceased
- 1998-06-15 ZA ZA985203A patent/ZA985203B/xx unknown
- 1998-06-15 EP EP98928886A patent/EP0989983B1/en not_active Expired - Lifetime
- 1998-06-15 CN CN98808124A patent/CN1266433A/zh active Pending
- 1998-06-15 JP JP50449099A patent/JP2002504144A/ja not_active Ceased
- 1998-06-15 AT AT98928886T patent/ATE273299T1/de not_active IP Right Cessation
- 1998-06-15 DE DE69825589T patent/DE69825589T2/de not_active Expired - Lifetime
- 1998-06-15 WO PCT/US1998/011495 patent/WO1998057960A1/en active IP Right Grant
- 1998-06-15 NZ NZ501376A patent/NZ501376A/en not_active IP Right Cessation
- 1998-06-15 ES ES98928886T patent/ES2224408T3/es not_active Expired - Lifetime
- 1998-06-15 CA CA002293714A patent/CA2293714C/en not_active Expired - Fee Related
- 1998-06-15 HU HU0003138A patent/HUP0003138A3/hu unknown
- 1998-06-15 PE PE1998000505A patent/PE104798A1/es not_active Application Discontinuation
- 1998-06-16 MY MYPI98002697A patent/MY143570A/en unknown
- 1998-06-16 AR ARP980102862A patent/AR012991A1/es unknown
-
1999
- 1999-12-08 IL IL133386A patent/IL133386A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2224408T3 (es) | 2005-03-01 |
| WO1998057960A1 (en) | 1998-12-23 |
| MY143570A (en) | 2011-05-31 |
| AU8058098A (en) | 1999-01-04 |
| CA2293714A1 (en) | 1998-12-23 |
| DE69825589D1 (de) | 2004-09-16 |
| KR20010013822A (ko) | 2001-02-26 |
| CN1266433A (zh) | 2000-09-13 |
| HUP0003138A3 (en) | 2002-11-28 |
| KR100640672B1 (ko) | 2006-11-02 |
| IL133386A0 (en) | 2001-04-30 |
| NZ501376A (en) | 2002-03-28 |
| TW587935B (en) | 2004-05-21 |
| AR012991A1 (es) | 2000-11-22 |
| ATE273299T1 (de) | 2004-08-15 |
| PE104798A1 (es) | 1999-11-06 |
| EP0989983A1 (en) | 2000-04-05 |
| EP0989983B1 (en) | 2004-08-11 |
| JP2002504144A (ja) | 2002-02-05 |
| IL133386A (en) | 2006-12-10 |
| AU753658B2 (en) | 2002-10-24 |
| CA2293714C (en) | 2009-09-08 |
| HUP0003138A2 (hu) | 2001-06-28 |
| DE69825589T2 (de) | 2005-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0004148A3 (en) | Inhibitors of farnesyl protein transferase | |
| IL124197A (en) | Inhibitors of farnesyl protein transferase | |
| IL126833A0 (en) | Inhibitors of protein farnesyl transferase | |
| EP0918771A4 (en) | THIADIOXOBENZODIAZEPINES FOR USE AS FARNESYL PROTEIN TRANSFERASE INHIBITORS | |
| EP0696593A3 (en) | Farnesyl protein transferase inhibitors | |
| AU5772698A (en) | Inhibitors of farnesyl protein transferase | |
| HU9500934D0 (en) | Imidazole-containing inhibitors of farnesyl protein transferase | |
| IL123155A0 (en) | 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors | |
| EP1027042A4 (en) | FARNESYL PROTEIN TRANSFERASE INHIBITORS | |
| HK1034450A1 (en) | Farnesyl protein transferase inhibitors for treating arthropathies | |
| GB9809869D0 (en) | Inhibition of protein kinases | |
| PL348294A1 (en) | Farnesyl protein transferase inhibitors | |
| ZA985203B (en) | Compounds useful for inhibition of farnesyl protein transferase | |
| AU5164898A (en) | Thioproline-containing inhibitors of farnesyl protein transferase | |
| ZA986623B (en) | Hydantoin derivatives having an inhibitor activity for farnesyl transferase | |
| ZA985211B (en) | Benzo (5,6) cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors | |
| HUP0202152A2 (en) | Tricyclyc farnesyl protein transferase inhibitors | |
| ZA985210B (en) | Compounds for the inhibition of farnesyl protein transferase | |
| ZA985214B (en) | Compounds useful for inhibition of farnesyl protein transferase | |
| HUP0002186A3 (en) | Compounds useful for inhibition of farnesyl protein transferase | |
| IL130453A0 (en) | Farnesyl transferase inhibitors | |
| HUP9903221A3 (en) | Inhibitors of protein farnesyl transferase | |
| ZA971621B (en) | Inhibitors of farnesyl protein transferase | |
| IL149870A0 (en) | Inhibitors of farnesyl protein transferase | |
| GB9609981D0 (en) | Inhibitors of farnesyl-protien transferase |